xylocaine-mpf with epi
Generic: xylocaine-mpf with epi
Labeler: hf acquisition co llc, dba healthfirstDrug Facts
Product Profile
Brand Name
xylocaine-mpf with epi
Generic Name
xylocaine-mpf with epi
Labeler
hf acquisition co llc, dba healthfirst
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
epinephrine bitartrate .005 mg/mL, lidocaine hydrochloride anhydrous 20 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
51662-1550
Product ID
51662-1550_e3cada58-aa1c-8792-e053-2a95a90a388f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA006488
Listing Expiration
2026-12-31
Marketing Start
2021-06-28
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
516621550
Hyphenated Format
51662-1550
Supplemental Identifiers
RxCUI
UPC
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
xylocaine-mpf with epi (source: ndc)
Generic Name
xylocaine-mpf with epi (source: ndc)
Application Number
NDA006488 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .005 mg/mL
- 20 mg/mL
Packaging
- 25 POUCH in 1 CASE (51662-1550-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1550-2) / 20 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "spl_id": "e3cada58-aa1c-8792-e053-2a95a90a388f", "openfda": {"upc": ["0363323489021"], "unii": ["30Q7KI53AK", "EC2CNF7XFP"], "rxcui": ["1010688"], "spl_set_id": ["c5dcb0e5-2624-9c9c-e053-2995a90a6d65"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "25 POUCH in 1 CASE (51662-1550-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1550-2) / 20 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1550-3", "marketing_start_date": "20210628"}], "brand_name": "XYLOCAINE-MPF WITH EPI", "product_id": "51662-1550_e3cada58-aa1c-8792-e053-2a95a90a388f", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1550", "generic_name": "XYLOCAINE-MPF WITH EPI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "XYLOCAINE-MPF WITH EPI", "active_ingredients": [{"name": "EPINEPHRINE BITARTRATE", "strength": ".005 mg/mL"}, {"name": "LIDOCAINE HYDROCHLORIDE ANHYDROUS", "strength": "20 mg/mL"}], "application_number": "NDA006488", "marketing_category": "NDA", "marketing_start_date": "20210628", "listing_expiration_date": "20261231"}